The Effectiveness of Compassion-Focused Therapy on Pain Catastrophizing, Sexual Function, and Resilience in Women with Multiple Sclerosis (MS)

Document Type : Original Article


1 Department of Psychology, Faculty of Humanities, Tarbiat Modares University, Tehran, Iran

2 Department of Psychology, Faculty of Literature and Human Sciences, University of Guilan, Rasht, Iran

3 Department of Psychology, Islamic Azad University, Ardabil Branch, Ardabil, Iran

4 Department of Psychology, Islamic Azad University, Garmsar Branch, Semnan, Iran

5 Department of Psychology, Islamic Azad University, Islamshahr Branch, Tehran, Iran



Introduction: The present study was conducted to determine the effectiveness of compassion-focused therapy on pain catastrophizing, sexual function, and resilience in women with Multiple Sclerosis (MS).
Method: The method of the present research was semi-experimental and its design was pre-test-post-test with a control group. The study's statistical population included patients with MS in Tehran in 2022. Among the eligible patients, 30 women with MS were randomly assigned to the intervention group (n=15), and the control group (n=15). The collection tools included pain catastrophizing (Sullivan et al. 1995), women's sexual function (Isidori et al. 2010), and resilience (Connor and Davidson, 2003) questionnaires. The intervention group received eight sessions of 90-minute therapy focused on compassion, but the control group did not receive any intervention. Finally, the obtained data were analyzed by multivariate analysis of covariance by SPSS-24.
Results: The results showed that compassion-focused therapy significantly reduces rumination (39.87), magnification (53.14), helplessness (35.42), sexual function (20.27), and resilience (17.65) in women with MS (P<0.001).
Conclusion: The findings of this research indicated the effectiveness of compassion-focused therapy on women with MS. Since women experienced many problems during MS, it is necessary to take measures to improve their mental and physical health.


  1. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Multiple Sclerosis Journal. 2020;26(14):1816-21. DOI: 10.1177/1352458520970841
  2. Benedict RH, Amato MP, DeLuca J, Geurts JJ. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. The Lancet Neurology. 2020;19(10):860-71.
  3. Misicka E, Davis MF, Kim W, Brugger SW, Beales J, Loomis S, et al. A higher burden of multiple sclerosis genetic risk confers an earlier onset. Multiple Sclerosis Journal. 2022;28(8):1189-97.
  4. Mirmosayyeb O, Shaygannejad V, Bagherieh S, Hosseinabadi AM, Ghajarzadeh M. Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis. Neurological Sciences. 2022;43:233-41. DOI: 10.1007/s10072-021-05750-w
  5. Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RH, Zivadinov R, et al. Epidemiology and treatment of multiple sclerosis in elderly populations. Nature Reviews Neurology. 2019;15(6):329-42. DOI: 10.1038/s41582-019-0183-3
  6. O'Mahony J, Salter A, Ciftci-Kavaklioglu B, Fox RJ, Cutter GR, Marrie RA. Physical and Mental Health–Related Quality of Life Trajectories Among People With Multiple Sclerosis. Neurology. 2022;99(14):e1538-e48. DOI: 10.1212/WNL.0000000000200931
  7. Bagheri-Sheykhangafshe F, Fathi-Ashtiani M, Fathi-Ashtiani A. Psychological Distress in Patients With Multiple Sclerosis and Epilepsy in the COVID-19 Pandemic: A Systematic Review. Caspian Journal of Neurological Sciences. 2022:133-42.
  8. Heitmann H, Andlauer TF, Korn T, Mühlau M, Henningsen P, Hemmer B, et al. Fatigue, depression, and pain in multiple sclerosis: how neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms. Multiple Sclerosis Journal. 2022;28(7):1020-7. DOI: 10.1177/1352458520972279
  9. Russo M, Naro A, Leo A, Sessa E, D’Aleo G, Bramanti P, et al. Evaluating Sativex® in neuropathic pain management: a clinical and neurophysiological assessment in multiple sclerosis. Pain Medicine. 2016;17(6):1145-54. DOI: 10.1093/pm/pnv080
  10. Yilmazer C, Lamers I, Solaro C, Feys P. Clinical perspective on pain in multiple sclerosis. Multiple Sclerosis Journal. 2022;28(4):502-11.
  11. Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low‐dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2018;38(3):382-9.
  12. Gromisch ES, Kerns RD, Beauvais J. “I battle pain every single day”: Pain-related illness intrusiveness among persons with multiple sclerosis. Rehabilitation psychology. 2019;64(3):269. DOI: 10.1037/rep0000273
  13. Carvalho T, Gomes C, Rodrigues A, da Motta C. Neuropathic pain, cognitive fusion, and alexithymia in patients with multiple sclerosis: Cross‐sectional evidence for an explanatory model of anxiety symptoms. Journal of Clinical Psychology. 2023.
  14. Valentine TR, Alschuler KN, Ehde DM, Kratz AL. Prevalence, co-occurrence, and trajectories of pain, fatigue, depression, and anxiety in the year following multiple sclerosis diagnosis. Multiple Sclerosis Journal. 2022;28(4):620-31.
  15. Jensen MP, Ehde DM, Gertz KJ, Stoelb BL, Dillworth TM, Hirsh AT, et al. Effects of self-hypnosis training and cognitive restructuring on daily pain intensity and catastrophizing in individuals with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis. 2010;59(1):45-63.
  16. Heitmann H, Biberacher V, Tiemann L, Buck D, Loleit V, Selter RC, et al. Prevalence of neuropathic pain in early multiple sclerosis. Multiple Sclerosis Journal. 2016;22(9):1224-30. DOI: 10.1177/1352458515613643
  17. Bientinesi R, Gavi F, Coluzzi S, Nociti V, Marturano M, Sacco E. Neurologic Urinary Incontinence, Lower Urinary Tract Symptoms and Sexual Dysfunctions in Multiple Sclerosis: Expert Opinions Based on the Review of Current Evidences. Journal of Clinical Medicine. 2022;11(21):6572.
  18. Konstantinidis C, Tzitzika M, Bantis A, Nikolia A, Samarinas M, Kratiras Z, et al. Female sexual dysfunction among Greek women with multiple sclerosis: correlations with organic and psychological factors. Sexual medicine. 2019;7(1):19-25. DOI: 10.1016/j.esxm.2018.11.003
  19. Polat Dunya C, Tülek Z, Kürtüncü M, Gündüz T, Panicker JN, Eraksoy M. Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting overactive bladder. Neurourology and Urodynamics. 2021;40(6):1661-9.
  20. Altunan B, Gundogdu AA, Ozcaglayan TIK, Unal A, Turgut N. The effect of pelvic floor exercise program on incontinence and sexual dysfunction in multiple sclerosis patients. International urology and nephrology. 2021;53:1059-65. DOI: 10.1007/s11255-021-02804-y
  21. Drulovic J, Kisic-Tepavcevic D, Pekmezovic T. Epidemiology, diagnosis and management of sexual dysfunction in multiple sclerosis. Acta Neurologica Belgica. 2020;120:791-7. DOI: 10.1007/s13760-020-01323-4
  22. Polat Dunya C, Tulek Z, Uchiyama T, Haslam C, Panicker JN. Systematic review of the prevalence, symptomatology and management options of sexual dysfunction in women with multiple sclerosis. Neurourology and urodynamics. 2020;39(1):83-95.
  23. Gava G, Visconti M, Salvi F, Bartolomei I, Seracchioli R, Meriggiola MC. Prevalence and psychopathological determinants of sexual dysfunction and related distress in women with and without multiple sclerosis. The journal of sexual medicine. 2019;16(6):833-42. DOI: 10.1016/j.jsxm.2019.03.011
  24. Kołtuniuk A, Przestrzelska M, Karnas A, Rosińczuk J. The association between sexual disorders and the quality of life of woman patients with multiple sclerosis: findings of a prospective, observational, and cross-sectional survey. Sexual medicine. 2020;8(2):297-306. doi: 10.1016/j.esxm.2020.02.009
  25. Novak AM, Lev-Ari S. Resilience, Stress, Well-Being, and Sleep Quality in Multiple Sclerosis. Journal of Clinical Medicine. 2023;12(2):716.
  26. Gajofatto A, Donisi V, Busch IM, Gobbin F, Butturini E, Calabrese M, et al. Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis. BMJ open. 2019;9(8):e030469. DOI: 10.1136/bmjopen-2019-030469
  27. Martin S, Kasser SL. The role of resilience: Physical activity continuation after falling in adults with multiple sclerosis. Disability and health journal. 2021;14(2):101046.
  28. Giovannetti AM, Quintas R, Tramacere I, Giordano A, Confalonieri P, Messmer Uccelli M, et al. A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study. PloS one. 2020;15(4):e0231380.  DOI: 10.1371/journal.pone.0231380
  29. Kasser SL, Zia A. Mediating role of resilience on quality of life in individuals with multiple sclerosis: a structural equation modeling approach. Archives of Physical Medicine and Rehabilitation. 2020;101(7):1152-61.
  30. Giovannetti AM, Solari A, Pakenham KI. Effectiveness of a group resilience intervention for people with multiple sclerosis delivered via frontline services. Disability and Rehabilitation. 2022;44(22):6582-92.
  31. Swanepoel I, van Staden W, Fletcher L. Psychological resilience and vulnerability as mediators between adverse life events and fatigue, motor dysfunction, and paresthesia in multiple sclerosis. Psychosomatic medicine. 2020;82(2):138-46. DOI: 10.1097/PSY.0000000000000770
  32. Nery-Hurwit M, Yun J, Ebbeck V. Examining the roles of self-compassion and resilience on health-related quality of life for individuals with Multiple Sclerosis. Disability and health journal. 2018;11(2):256-61.
  33. Simpson R, Posa S, Bruno T, Simpson S, Wasilewski MB, Robinson LR, et al. Conceptualization, use, and outcomes associated with compassion in the care of people with multiple sclerosis: a scoping review. Journal of Neurology. 2022:1-23. doi: 10.1007/s00415-022-11497-x
  34. Miller A, Spada V, Beerkircher D, Kreitman RR. Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing—remitting multiple sclerosis. Multiple Sclerosis Journal. 2008;14(4):494-9.
  35. Giménez-Llort L, Martín-González JJ, Maurel S. Secondary impacts of COVID-19 pandemic in fatigue, self-compassion, physical and mental health of people with multiple sclerosis and caregivers: the teruel study. Brain sciences. 2021;11(9):1233.
  36. Dahmardeh H, Sadooghiasl A, Mohammadi E, Kazemnejad A. The experiences of patients with multiple sclerosis of self-compassion: A qualitative content analysis. BioMedicine. 2021;11(4):35. doi: 10.37796/2211-8039.1211
  37. Zarotti N, Poz R, Fisher P. Compassion-focused therapy for an older adult with motor functional neurological disorder: A case study. Clinical Gerontologist. 2022:1-10.
  38. Kılıç A, Hudson J, McCracken LM, Ruparelia R, Fawson S, Hughes LD. A systematic review of the effectiveness of self-compassion-related interventions for individuals with chronic physical health conditions. Behavior Therapy. 2021;52(3):607-25.
  39. Carletto S, Cavalera C, Sadowski I, Rovaris M, Borghi M, Khoury B, et al. Mindfulness-based interventions for the improvement of well-being in people with multiple sclerosis: a systematic review and meta-analysis. Psychosomatic medicine. 2020;82(6):600-13. DOI: 10.1097/PSY.0000000000000819
  40. Lorefice L, D’Alterio MN, Firinu D, Fenu G, Cocco E. Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives. International Journal of Women's Health. 2023:103-9. doi: 10.2147/IJWH.S334719
  41. Faul F, Erdfelder E, Lang A-G, Buchner A. G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior research methods. 2007;39(2):175-91. DOI: 10.3758/bf03193146
  42. Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychological assessment. 1995;7(4):524.
  43. Mohamadi S, Dehghani M, Heidari M, Sedaghat M, Khatibi A. The evaluation of pain-related psychological similarities among patients with musculoskeletal chronic pain and their spouses. International Journal of Behavioral Sciences. 2013;7(1):57-66.
  44. Isidori AM, Pozza C, Esposito K, Giugliano D, Morano S, Vignozzi L, et al. Outcomes assessment: Development and validation of a 6-item version of the Female Sexual Function Index (FSFI) as a diagnostic tool for female sexual dysfunction. The journal of sexual medicine. 2010;7(3):1139-46.
  45. Shairi MR, Asghari Moghadam MA, Rahmati N. The study of the psychometric properties of the 6-item version of the female sexual function index (FSFI-6) amongest Iranian women. Nursing and Midwifery Journal. 2014;12(7):532-43.
  46. Connor KM, Davidson JR. Development of a new resilience scale: The Connor‐Davidson resilience scale (CD‐RISC). Depression and anxiety. 2003;18(2):76-82.
  47. Bagheri Sheykhangafshe F, Alizadeh D, Savabi Niri V, Asgari F, Ghodrat G. The role of internet addiction, mindfulness and resilience in predicting students' mental health during the coronavirus 2019 pandemic. Quarterly Journal of Child Mental Health. 2021;8(3):1-14. DOI: 10.52547/jcmh.8.3.2
  48. Gilbert P. An introduction to compassion focused therapy in cognitive behavior therapy. International Journal of Cognitive Therapy. 2010;3(2):97-112.